Peter Chansky, MD
Dermatology · Daly City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 2 carriers
- Office
- 1
- Since medical school
- 8 years
- Perelman School of Med at the University of Pennsylvania, 2018
Offices
1 location · Csi Medical Group · 104 clinicians in this group
Hospitals listed: California Pacific Medical Ctr-Davies Campus Hosp. That is not proof they admit you there this week.
Plans that list them
4 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chansky’s office at (650) 994-3238 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
4 of 4 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A178808 · Current
Licensed to practise in California · since 2022 · expires 2028-05-31 · Perelman School of Medicine at the University of Pennsylvania.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Dermatology - Dermatology
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Ctr-Davies Campus HospSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.187, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Ctr-Davies Campus Hosp
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 1 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.187 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 232 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.56 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 10 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 257 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 721 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.49) · 2,031 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.45) · 2,032 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.35 (0.94 to 5.76) · 419 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 211 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.84 (1.24 to 4.44) · 414 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.95 (2.91 to 20.98) · 218 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.61 (1.47 to 9.75) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 52 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 1.28) · 1,461 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 58 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.756 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 91 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 65.3 · 84 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -26.6 · 115 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 142 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 55 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 25 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 312 cases | No different | Jan 2024 – Dec 2024 |
What patients said (602 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$98,891
Medicare paid this office $98,891 for 236 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 132 | $26,309 | $113 |
| New patient visit (45+ min) | 64 | $9,373 | $146 |
| Short return visit (20+ min) | 77 | $9,196 | $77 |
| Destruction of precancer skin growth, 15 or more growths | 43 | $8,883 | $165 |
| Destruction of precancer skin growth, 1 growth | 116 | $8,310 | $51 |
See all 12 services
| Return visit (30+ min) | 132 | $26,309 | $113 |
| New patient visit (45+ min) | 64 | $9,373 | $146 |
| Short return visit (20+ min) | 77 | $9,196 | $77 |
| Destruction of precancer skin growth, 15 or more growths | 43 | $8,883 | $165 |
| Destruction of precancer skin growth, 1 growth | 116 | $8,310 | $51 |
| Destruction of skin growth, 1-14 growths | 56 | $7,378 | $105 |
| Destruction of precancer skin growth, 2-14 growths | 101 | $4,622 | $7 |
| New patient visit (30+ min) | 47 | $4,181 | $89 |
| Biopsy of related skin growth, first growth | 37 | $3,451 | $88 |
| Simple or single drainage of skin abscess | 15 | $1,837 | $115 |
| Injection into skin growth, 1-7 growths | 15 | $956 | $38 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 16 | $29 | None |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 12 | More than 66% of doctors who do this |
| Removal of nail tissue | 1-10 | None |
| Removal of skin lesions | 673 | More than 89% of doctors who do this |
| Removal of tissue | 1-10 | None |
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 156 | More than 81% of doctors who do this |
Procedures year by year
| Procedure | 2022 | 2023 | 2024 |
|---|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 103 | 604 | 668 |
| Destruction of precancer skin growth, 1 growth | 28 | 140 | 163 |
| Destruction of skin growth, 1-14 growths | – | 71 | 70 |
| Biopsy of related skin growth, first growth | 17 | 67 | 39 |
| Destruction of precancer skin growth, 15 or more growths | – | 40 | 54 |
| Injection into skin growth, 1-7 growths | – | – | 25 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
236 Original Medicare patients in 2024. Average age 74 · Women 30% · Also on Medicaid 15% · Health risk score 0.93. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 61% · Diabetes 22% · Coronary heart disease 21% · Depression 21% · Cancer 16% · Chronic kidney disease 14% · Atrial fibrillation 13% · Heart failure 11% · COPD 9% · Stroke 8% · Dementia 7%.
The office billed $220,159, Medicare allowed $132,607 and paid $98,891; for 1,668 services of 42 kinds; $29 of it was for drugs given in the office and $98,862 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 236 | 1,668 | 74 | 0.93 | $220,159 | $98,891 |
| 2023 | 216 | 1,408 | 75 | 1.08 | $184,255 | $81,648 |
| 2022 | 54 | 262 | 75 | 0.98 | $37,098 | $17,183 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Return visit (30+ min) | 81 | $13,844 | $107 |
| Short return visit (20+ min) | 71 | $9,006 | $80 |
| Destruction of skin growth, 1-14 growths | 62 | $7,671 | $108 |
| New patient visit (30+ min) | 79 | $6,923 | $88 |
| Destruction of precancer skin growth, 1 growth | 98 | $6,760 | $48 |
| Destruction of precancer skin growth, 15 or more growths | 31 | $6,602 | $165 |
| New patient visit (45+ min) | 51 | $6,487 | $127 |
| Biopsy of related skin growth, first growth | 59 | $6,289 | $94 |
| Destruction of precancer skin growth, 2-14 growths | 84 | $4,198 | $7 |
| Biopsy of related skin growth, each additional growth | 14 | $922 | $51 |
2022: 6 services
| Return visit (30+ min) | 22 | $3,697 | $119 |
| Short return visit (20+ min) | 19 | $1,863 | $85 |
| Biopsy of related skin growth, first growth | 15 | $1,765 | $104 |
| Destruction of precancer skin growth, 1 growth | 21 | $1,450 | $52 |
| New patient visit (30+ min) | 13 | $1,244 | $96 |
| Destruction of precancer skin growth, 2-14 growths | 19 | $702 | $7 |
Drugs they prescribed that Part D paid
$282,319
Pharmacies billed $282,319 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 409) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
360 generic and 49 brand-name prescriptions · $282,319 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Clobetasol Propionate | 74 | $3,264 | $44 |
| Fluorouracil | 24 | $1,649 | $69 |
| Ketoconazole | 112 | $1,421 | $13 |
| Azelaic Acid | 13 | $1,405 | $108 |
| Triamcinolone Acetonide | 39 | $357 | $9 |
Year by year
| 2024 | 409 | 180 | 0% (0) | 12% | $282,319 |
| 2023 | 328 | 151 | 0% (0) | 6% | $78,730 |
| 2022 | 173 | 76 | 0% (0) | 8% | $37,553 |
| 2021 | 350 | 98 | 0% (0) | 13% | $403,210 |
| 2020 | 192 | 68 | 0% (0) | 10% | $35,550 |
| 2019 | 158 | 48 | 0% (0) | 9% | $16,805 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Clobetasol Propionate | 56 | $3,449 | $62 |
| Azelaic Acid | 11 | $1,668 | $152 |
| Ketoconazole | 75 | $1,181 | $16 |
| Fluorouracil | 17 | $1,127 | $66 |
| Triamcinolone Acetonide | 50 | $566 | $11 |
| Ammonium Lactate | 12 | $355 | $30 |
| Mupirocin | 18 | $204 | $11 |
2022: 3 drugs
| Clobetasol Propionate | 23 | $1,971 | $86 |
| Ketoconazole | 47 | $924 | $20 |
| Triamcinolone Acetonide | 14 | $149 | $11 |
2021: 7 drugs
| Humira(Cf) | 12 | $145,162 | $12,097 |
| Clobetasol Propionate | 56 | $6,026 | $108 |
| Ketoconazole | 51 | $1,197 | $23 |
| Triamcinolone Acetonide | 53 | $650 | $12 |
| Ammonium Lactate | 19 | $518 | $27 |
| Hydrocortisone | 16 | $126 | $8 |
| Mupirocin | 20 | $95 | $5 |
2020: 6 drugs
| Metronidazole | 12 | $1,245 | $104 |
| Halobetasol Propionate | 12 | $1,170 | $97 |
| Fluocinonide | 16 | $871 | $54 |
| Ketoconazole | 26 | $396 | $15 |
| Triamcinolone Acetonide | 21 | $347 | $17 |
| Hydrocortisone | 12 | $117 | $10 |
2019: 3 drugs
| Clotrimazole | 20 | $733 | $37 |
| Triamcinolone Acetonide | 23 | $307 | $13 |
| Ketoconazole | 16 | $256 | $16 |
Money from drug and device companies
$26,540 in 2025
| 2025 | 25 | 307 | $16,569 | $26,540 |
| 2024 | 19 | 263 | None | $8,262 |
| 2023 | 22 | 213 | None | $6,464 |
| 2022 | 14 | 43 | None | $1,316 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Sun Pharmaceutical Industries | Winlevi | $12,383 | 32 payments
|
| Genzyme | Dupixent | $4,283 | 23 payments
|
| Regeneron Healthcare Solutions | Dupixent | $3,361 | 14 payments
|
| Abbvie | Skyrizi | $1,378 | 58 payments
|
| Arcutis Biotherapeutics | Zoryve | $1,019 | 37 payments
|
| Galderma Laboratories L.P. | Nemluvio | $827 | 26 payments
|
See all 304 published payments
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-12-22 | Cabtreo | $24 |
| Abbvie | Meals · 2025-12-18 | Skyrizi | $15 |
| Arcutis Biotherapeutics | Meals · 2025-12-18 | Zoryve | $29 |
| Galderma Laboratories L.P. | Meals · 2025-12-17 | Nemluvio | $8 |
| Abbvie | Meals · 2025-12-16 | Skyrizi | $28 |
| Incyte | Meals · 2025-12-16 | Opzelura | $28 |
| Genzyme | Paid to speak or teach · 2025-12-16 | Dupixent | $3,455 |
| Genzyme | Travel · 2025-12-16 | Dupixent | $35 |
| Genzyme | Meals · 2025-12-16 | Dupixent | $120 |
| Galderma Laboratories L.P. | Meals · 2025-12-16 | Nemluvio | $20 |
| Abbvie | Meals · 2025-12-12 | Rinvoq | $15 |
| Abbvie | Meals · 2025-12-12 | Rinvoq | $27 |
| Galderma Laboratories L.P. | Meals · 2025-12-10 | Nemluvio | $33 |
| Genzyme | Meals · 2025-12-08 | Dupixent | $31 |
| Arcutis Biotherapeutics | Meals · 2025-12-08 | Zoryve | $26 |
| Abbvie | Meals · 2025-12-04 | Skyrizi | $24 |
| Galderma Laboratories L.P. | Meals · 2025-12-03 | Nemluvio | $133 |
| Novartis Pharmaceuticals | Meals · 2025-12-02 | Rhapsido | $19 |
| Incyte | Meals · 2025-12-02 | Opzelura | $29 |
| Ucb | Meals · 2025-12-01 | Bimzelx | $17 |
| Regeneron Healthcare Solutions | Consulting · 2025-11-21 | Dupixent | $1,002 |
| Regeneron Healthcare Solutions | Consulting · 2025-11-21 | Dupixent | $2,004 |
| Abbvie | Meals · 2025-11-20 | Skyrizi | $31 |
| Regeneron Healthcare Solutions | Meals · 2025-11-20 | Dupixent | $34 |
| Arcutis Biotherapeutics | Meals · 2025-11-20 | Zoryve | $19 |
| Abbvie | Meals · 2025-11-19 | Rinvoq | $26 |
| Ucb | Meals · 2025-11-19 | Bimzelx | $125 |
| Incyte | Meals · 2025-11-19 | Opzelura | $16 |
| LEO Pharma | Meals · 2025-11-19 | Adbry | $16 |
| Incyte | Meals · 2025-11-18 | Opzelura | $15 |
| Sun Pharmaceutical Industries | Meals · 2025-11-17 | Winlevi | $33 |
| Genzyme | Meals · 2025-11-13 | Dupixent | $24 |
| Organon | Meals · 2025-11-13 | Vtama | $30 |
| Arcutis Biotherapeutics | Meals · 2025-11-12 | Zoryve | $9 |
| Regeneron Healthcare Solutions | Meals · 2025-11-11 | Libtayo | $22 |
| Journey Medical | Meals · 2025-11-10 | None | $28 |
| Galderma Laboratories L.P. | Meals · 2025-11-07 | Nemluvio | $14 |
| Galderma Laboratories L.P. | Meals · 2025-11-06 | Nemluvio | $16 |
| Sun Pharmaceutical Industries | Meals · 2025-11-06 | Winlevi | $26 |
| Sun Pharmaceutical Industries | Travel · 2025-11-06 | Winlevi | $35 |
| Sun Pharmaceutical Industries | Travel · 2025-11-06 | Winlevi | $4 |
| Arcutis Biotherapeutics | Meals · 2025-11-06 | Zoryve | $16 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-05 | Sotyktu | $40 |
| Ucb | Meals · 2025-11-04 | Bimzelx | $15 |
| Incyte | Meals · 2025-11-04 | Opzelura | $30 |
| Cipher Pharmaceuticals US | Meals · 2025-10-30 | Natroba | $25 |
| Ucb | Meals · 2025-10-29 | Bimzelx | $3 |
| LEO Pharma | Meals · 2025-10-29 | Adbry | $11 |
| Ucb | Meals · 2025-10-28 | Bimzelx | $29 |
| Sun Pharmaceutical Industries | Meals · 2025-10-27 | Winlevi | $29 |
| STRATA Skin Sciences | Meals · 2025-10-27 | Xtrac | $23 |
| Novartis Pharmaceuticals | Meals · 2025-10-24 | Rhapsido | $35 |
| Lilly USA | Meals · 2025-10-23 | Taltz | $32 |
| Abbvie | Meals · 2025-10-23 | Rinvoq | $19 |
| Ucb | Meals · 2025-10-23 | Bimzelx | $4 |
| Ucb | Meals · 2025-10-23 | Bimzelx | $8 |
| Pfizer | Meals · 2025-10-22 | Litfulo | $28 |
| Galderma Laboratories L.P. | Meals · 2025-10-21 | Nemluvio | $12 |
| Arcutis Biotherapeutics | Meals · 2025-10-21 | Zoryve | $10 |
| Novartis Pharmaceuticals | Meals · 2025-10-20 | Rhapsido | $23 |
| Arcutis Biotherapeutics | Meals · 2025-10-16 | Zoryve | $27 |
| Verrica Pharmaceuticals | Meals · 2025-10-15 | Ycanth | $25 |
| Incyte | Meals · 2025-10-15 | Opzelura | $30 |
| LEO Pharma | Meals · 2025-10-15 | Spevigo | $7 |
| Janssen Biotech | Education · 2025-10-13 | Tremfya | $99 |
| Galderma Laboratories L.P. | Meals · 2025-10-13 | None | $27 |
| Incyte | Meals · 2025-10-10 | Opzelura | $26 |
| Genzyme | Meals · 2025-10-08 | Dupixent | $29 |
| Galderma Laboratories L.P. | Meals · 2025-10-08 | Nemluvio | $27 |
| Sun Pharmaceutical Industries | Paid to speak or teach · 2025-10-08 | Winlevi | $3,249 |
| Arcutis Biotherapeutics | Meals · 2025-10-08 | Zoryve | $11 |
| LEO Pharma | Meals · 2025-10-07 | Anzupgo | $24 |
| Galderma Laboratories L.P. | Meals · 2025-10-02 | Nemluvio | $15 |
| Abbvie | Meals · 2025-09-30 | Skyrizi | $31 |
| Genzyme | Meals · 2025-09-30 | Dupixent | $49 |
| Abbvie | Meals · 2025-09-25 | Rinvoq | $16 |
| Galderma Laboratories L.P. | Meals · 2025-09-25 | Nemluvio | $18 |
| Sun Pharmaceutical Industries | Meals · 2025-09-24 | Winlevi | $163 |
| Ucb | Meals · 2025-09-23 | Bimzelx | $28 |
| Sun Pharmaceutical Industries | Meals · 2025-09-23 | Winlevi | $16 |
| LEO Pharma | Meals · 2025-09-22 | Adbry | $12 |
| Janssen Biotech | Meals · 2025-09-18 | Tremfya | $15 |
| Organon | Meals · 2025-09-18 | None | $32 |
| Lilly USA | Meals · 2025-09-17 | Taltz | $29 |
| Regeneron Healthcare Solutions | Meals · 2025-09-17 | Dupixent | $21 |
| Ucb | Meals · 2025-09-17 | Bimzelx | $66 |
| Sun Pharmaceutical Industries | Meals · 2025-09-16 | Winlevi | $31 |
| Arcutis Biotherapeutics | Meals · 2025-09-15 | Zoryve | $31 |
| Ucb | Meals · 2025-09-12 | Bimzelx | $5 |
| Incyte | Meals · 2025-09-12 | Opzelura | $28 |
| Ucb | Meals · 2025-09-11 | Bimzelx | $10 |
| Regeneron Healthcare Solutions | Meals · 2025-09-09 | Libtayo | $30 |
| Genzyme | Meals · 2025-09-09 | Dupixent | $14 |
| Galderma Laboratories L.P. | Meals · 2025-09-09 | Nemluvio | $111 |
| Arcutis Biotherapeutics | Meals · 2025-09-09 | Zoryve | $32 |
| LEO Pharma | Meals · 2025-09-08 | Adbry | $8 |
| Janssen Biotech | Meals · 2025-09-05 | Tremfya | $40 |
| Almirall | Meals · 2025-09-05 | Klisyri | $23 |
| Galderma Laboratories L.P. | Meals · 2025-09-04 | Nemluvio | $35 |
| Abbvie | Meals · 2025-09-03 | Skyrizi | $127 |
| Arcutis Biotherapeutics | Meals · 2025-09-02 | Zoryve | $13 |
| Sun Pharmaceutical Industries | Travel · 2025-08-25 | Winlevi | $16 |
| Sun Pharmaceutical Industries | Meals · 2025-08-25 | Winlevi | $11 |
| Sun Pharmaceutical Industries | Travel · 2025-08-25 | Winlevi | $47 |
| Sun Pharmaceutical Industries | Travel · 2025-08-25 | Winlevi | $87 |
| Sun Pharmaceutical Industries | Travel · 2025-08-25 | Winlevi | $49 |
| Sun Pharmaceutical Industries | Travel · 2025-08-25 | Winlevi | $74 |
| Sun Pharmaceutical Industries | Travel · 2025-08-25 | Winlevi | $51 |
| Genzyme | Meals · 2025-08-21 | Dupixent | $43 |
| LEO Pharma | Meals · 2025-08-21 | Adbry | $16 |
| Galderma Laboratories L.P. | Meals · 2025-08-20 | Nemluvio | $29 |
| Incyte | Meals · 2025-08-19 | Opzelura | $25 |
| Galderma Laboratories L.P. | Meals · 2025-08-14 | Nemluvio | $6 |
| Galderma Laboratories L.P. | Meals · 2025-08-14 | Nemluvio | $5 |
| Galderma Laboratories L.P. | Meals · 2025-08-14 | Nemluvio | $9 |
| Sun Pharmaceutical Industries | Meals · 2025-08-14 | Winlevi | $30 |
| Arcutis Biotherapeutics | Meals · 2025-08-14 | Zoryve | $8 |
| Abbvie | Meals · 2025-08-13 | Rinvoq | $27 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-08-13 | Spevigo | $19 |
| Genzyme | Meals · 2025-08-13 | Dupixent | $80 |
| Arcutis Biotherapeutics | Meals · 2025-08-13 | Zoryve | $26 |
| Abbvie | Meals · 2025-08-12 | Skyrizi | $20 |
| Pfizer | Meals · 2025-08-08 | Litfulo | $26 |
| Galderma Laboratories L.P. | Meals · 2025-08-06 | Nemluvio | $33 |
| Novartis Pharmaceuticals | Meals · 2025-08-04 | Cosentyx | $33 |
| Arcutis Biotherapeutics | Meals · 2025-08-04 | Zoryve | $22 |
| Abbvie | Meals · 2025-07-30 | Skyrizi | $32 |
| Sun Pharmaceutical Industries | Paid to speak or teach · 2025-07-30 | Winlevi | $5,415 |
| Sun Pharmaceutical Industries | Travel · 2025-07-30 | Winlevi | $464 |
| Sun Pharmaceutical Industries | Travel · 2025-07-30 | Winlevi | $238 |
| Sun Pharmaceutical Industries | Travel · 2025-07-30 | Winlevi | $314 |
| Sun Pharmaceutical Industries | Meals · 2025-07-30 | Winlevi | $108 |
| Abbvie | Meals · 2025-07-29 | Rinvoq | $23 |
| Incyte | Meals · 2025-07-29 | Opzelura | $28 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-07-28 | Cabtreo | $21 |
| LEO Pharma | Meals · 2025-07-28 | Adbry | $23 |
| Genzyme | Meals · 2025-07-24 | Dupixent | $28 |
| Sun Pharmaceutical Industries | Meals · 2025-07-24 | Winlevi | $10 |
| Janssen Biotech | Meals · 2025-07-23 | Tremfya | $27 |
| Arcutis Biotherapeutics | Meals · 2025-07-22 | Zoryve | $13 |
| Abbvie | Meals · 2025-07-21 | Skyrizi | $1 |
| Abbvie | Meals · 2025-07-21 | Skyrizi | $28 |
| Galderma Laboratories L.P. | Meals · 2025-07-16 | None | $4 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-07-08 | Cabtreo | $23 |
| Janssen Biotech | Meals · 2025-07-07 | Tremfya | $28 |
| Arcutis Biotherapeutics | Meals · 2025-07-03 | Zoryve | $9 |
| Abbvie | Meals · 2025-07-01 | Skyrizi | $3 |
| Abbvie | Meals · 2025-07-01 | Skyrizi | $23 |
| Regeneron Healthcare Solutions | Meals · 2025-07-01 | Dupixent | $34 |
| Arcutis Biotherapeutics | Meals · 2025-06-28 | Zoryve | $29 |
| Janssen Biotech | Meals · 2025-06-26 | Tremfya | $33 |
| Ucb | Meals · 2025-06-26 | Bimzelx | $35 |
| Genzyme | Meals · 2025-06-26 | Dupixent | $14 |
| Lilly USA | Meals · 2025-06-24 | Taltz | $30 |
| Abbvie | Meals · 2025-06-24 | Skyrizi | $6 |
| Janssen Biotech | Meals · 2025-06-23 | Tremfya | $35 |
| Abbvie | Meals · 2025-06-23 | Skyrizi | $1 |
| Regeneron Healthcare Solutions | Meals · 2025-06-20 | Dupixent | $34 |
| Sun Pharmaceutical Industries | Paid to speak or teach · 2025-06-20 | Winlevi | $1,444 |
| Galderma Laboratories L.P. | Meals · 2025-06-17 | Nemluvio | $39 |
| Arcutis Biotherapeutics | Meals · 2025-06-17 | Zoryve | $18 |
| LEO Pharma | Meals · 2025-06-13 | Adbry | $19 |
| Ucb | Meals · 2025-06-10 | Bimzelx | $29 |
| Arcutis Biotherapeutics | Meals · 2025-06-10 | Zoryve | $21 |
| Arcutis Biotherapeutics | Meals · 2025-06-10 | Zoryve | $22 |
| Incyte | Meals · 2025-06-06 | Opzelura | $29 |
| Abbvie | Meals · 2025-06-05 | Rinvoq | $11 |
| Ucb | Meals · 2025-06-04 | Bimzelx | $125 |
| Janssen Biotech | Meals · 2025-06-02 | Tremfya | $26 |
| Arcutis Biotherapeutics | Meals · 2025-05-29 | Zoryve | $23 |
| Abbvie | Meals · 2025-05-28 | Skyrizi | $28 |
| Lilly USA | Meals · 2025-05-22 | Taltz | $5 |
| Lilly USA | Meals · 2025-05-22 | Taltz | $15 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-05-21 | Spevigo | $35 |
| Arcutis Biotherapeutics | Meals · 2025-05-21 | Zoryve | $163 |
| Incyte | Meals · 2025-05-20 | Opzelura | $27 |
| Sun Pharmaceutical Industries | Meals · 2025-05-20 | Winlevi | $22 |
| Abbvie | Meals · 2025-05-16 | Rinvoq | $20 |
| Incyte | Meals · 2025-05-16 | Opzelura | $11 |
| Abbvie | Meals · 2025-05-15 | Skyrizi | $6 |
| Regeneron Healthcare Solutions | Meals · 2025-05-15 | Dupixent | $33 |
| Arcutis Biotherapeutics | Meals · 2025-05-14 | Zoryve | $14 |
| Janssen Biotech | Meals · 2025-05-13 | Tremfya | $16 |
| Abbvie | Meals · 2025-05-12 | Skyrizi | $10 |
| Arcutis Biotherapeutics | Meals · 2025-05-12 | Zoryve | $23 |
| Regeneron Healthcare Solutions | Meals · 2025-05-09 | Dupixent | $19 |
| Sun Pharmaceutical Industries | Meals · 2025-05-08 | None | $143 |
| Genzyme | Meals · 2025-05-07 | Dupixent | $38 |
| Sun Pharmaceutical Industries | Meals · 2025-05-06 | Winlevi | $25 |
| Sun Pharmaceutical Industries | Meals · 2025-05-06 | Winlevi | $1 |
| Galderma Laboratories L.P. | Meals · 2025-05-02 | Nemluvio | $31 |
| Ucb | Meals · 2025-05-01 | Bimzelx | $125 |
| Genzyme | Meals · 2025-05-01 | Dupixent | $20 |
| Arcutis Biotherapeutics | Meals · 2025-05-01 | Zoryve | $4 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-04-30 | Spevigo | $33 |
| Incyte | Meals · 2025-04-30 | Opzelura | $29 |
| Galderma Laboratories L.P. | Meals · 2025-04-29 | Nemluvio | $110 |
| Genzyme | Meals · 2025-04-25 | Dupixent | $26 |
| Ucb | Meals · 2025-04-24 | Bimzelx | $19 |
| Arcutis Biotherapeutics | Meals · 2025-04-24 | Zoryve | $78 |
| Arcutis Biotherapeutics | Meals · 2025-04-24 | Zoryve | $30 |
| LEO Pharma | Meals · 2025-04-23 | Adbry | $25 |
| Novartis Pharmaceuticals | Meals · 2025-04-22 | Cosentyx | $34 |
| Abbvie | Meals · 2025-04-22 | Skyrizi | $11 |
| Abbvie | Meals · 2025-04-22 | Skyrizi | $10 |
| Abbvie | Meals · 2025-04-22 | Rinvoq | $31 |
| Genzyme | Meals · 2025-04-16 | Dupixent | $49 |
| LEO Pharma | Meals · 2025-04-16 | Adbry | $9 |
| Arcutis Biotherapeutics | Meals · 2025-04-15 | Zoryve | $16 |
| Abbvie | Meals · 2025-04-14 | Skyrizi | $26 |
| Regeneron Healthcare Solutions | Meals · 2025-04-11 | Dupixent | $34 |
| Galderma Laboratories L.P. | Meals · 2025-04-10 | Nemluvio | $18 |
| Organon | Meals · 2025-04-10 | Vtama | $200 |
| Sun Pharmaceutical Industries | Meals · 2025-04-10 | Winlevi | $17 |
| Abbvie | Meals · 2025-04-08 | Skyrizi | $15 |
| Abbvie | Meals · 2025-04-08 | Rinvoq | $14 |
| Abbvie | Meals · 2025-04-08 | Rinvoq | $14 |
| Galderma Laboratories L.P. | Meals · 2025-04-08 | Dysport | $24 |
| Lilly USA | Meals · 2025-04-03 | Taltz | $29 |
| Lilly USA | Meals · 2025-04-03 | Taltz | $4 |
| Ucb | Meals · 2025-04-02 | Bimzelx | $3 |
| Ucb | Meals · 2025-04-02 | Bimzelx | $19 |
| Genzyme | Meals · 2025-04-02 | Dupixent | $37 |
| Abbvie | Meals · 2025-03-27 | Rinvoq | $28 |
| Arcutis Biotherapeutics | Meals · 2025-03-27 | Zoryve | $29 |
| Arcutis Biotherapeutics | Meals · 2025-03-27 | Zoryve | $99 |
| Abbvie | Meals · 2025-03-26 | Skyrizi | $1 |
| Abbvie | Meals · 2025-03-26 | Skyrizi | $21 |
| Galderma Laboratories L.P. | Meals · 2025-03-26 | Nemluvio | $21 |
| Incyte | Meals · 2025-03-25 | Opzelura | $26 |
| Amgen | Meals · 2025-03-25 | Otezla | $28 |
| Lilly USA | Meals · 2025-03-20 | Taltz | $31 |
| Eli Lilly and | Meals · 2025-03-19 | Ebglyss | $119 |
| Amgen | Meals · 2025-03-19 | Otezla | $28 |
| Abbvie | Meals · 2025-03-18 | Skyrizi | $31 |
| Organon | Meals · 2025-03-18 | Vtama | $16 |
| Janssen Biotech | Meals · 2025-03-17 | Tremfya | $28 |
| Regeneron Healthcare Solutions | Meals · 2025-03-14 | Dupixent | $35 |
| Arcutis Biotherapeutics | Meals · 2025-03-13 | Zoryve | $22 |
| Abbvie | Meals · 2025-03-12 | Skyrizi | $148 |
| Abbvie | Meals · 2025-03-12 | None | $25 |
| Ucb | Meals · 2025-03-12 | Bimzelx | $9 |
| Ucb | Meals · 2025-03-12 | Bimzelx | $15 |
| Sun Pharmaceutical Industries | Meals · 2025-03-08 | None | $163 |
| Ucb | Meals · 2025-03-07 | Bimzelx | $34 |
| Abbvie | Meals · 2025-03-06 | Skyrizi | $11 |
| Abbvie | Meals · 2025-03-05 | Skyrizi | $27 |
| Arcutis Biotherapeutics | Meals · 2025-03-05 | Zoryve | $16 |
| Novartis Pharmaceuticals | Meals · 2025-03-04 | Cosentyx | $27 |
| Incyte | Meals · 2025-03-04 | Opzelura | $27 |
| Incyte | Meals · 2025-03-04 | Opzelura | $2 |
| Arcutis Biotherapeutics | Meals · 2025-03-04 | Zoryve | $27 |
| Lilly USA | Meals · 2025-03-03 | Taltz | $34 |
| Genzyme | Meals · 2025-03-03 | Dupixent | $21 |
| Abbvie | Meals · 2025-02-28 | Skyrizi | $20 |
| Abbvie | Meals · 2025-02-28 | Rinvoq | $27 |
| Organon | Meals · 2025-02-27 | Vtama | $33 |
| Regeneron Healthcare Solutions | Meals · 2025-02-26 | Dupixent | $23 |
| Janssen Biotech | Meals · 2025-02-25 | Tremfya | $13 |
| Arcutis Biotherapeutics | Meals · 2025-02-25 | Zoryve | $14 |
| Genentech USA | Meals · 2025-02-24 | Xolair | $31 |
| Abbvie | Meals · 2025-02-20 | Skyrizi | $13 |
| Novartis Pharmaceuticals | Meals · 2025-02-19 | Cosentyx | $7 |
| Novartis Pharmaceuticals | Meals · 2025-02-19 | Cosentyx | $10 |
| Novartis Pharmaceuticals | Meals · 2025-02-19 | Cosentyx | $11 |
| Abbvie | Meals · 2025-02-19 | Rinvoq | $34 |
| Genzyme | Meals · 2025-02-19 | Dupixent | $39 |
| Novartis Pharmaceuticals | Meals · 2025-02-18 | Cosentyx | $29 |
| Regeneron Healthcare Solutions | Meals · 2025-02-13 | Dupixent | $37 |
| Sun Pharmaceutical Industries | Meals · 2025-02-13 | Winlevi | $37 |
| Arcutis Biotherapeutics | Meals · 2025-02-13 | Zoryve | $21 |
| Janssen Biotech | Meals · 2025-02-11 | Tremfya | $29 |
| Lilly USA | Meals · 2025-02-11 | Taltz | $31 |
| Abbvie | Meals · 2025-02-05 | Skyrizi | $33 |
| Genzyme | Meals · 2025-02-04 | Dupixent | $38 |
| Organon | Meals · 2025-02-04 | Vtama | $19 |
| Abbvie | Meals · 2025-02-03 | Skyrizi | $27 |
| Abbvie | Meals · 2025-01-30 | Skyrizi | $33 |
| Abbvie | Meals · 2025-01-30 | Skyrizi | $21 |
| Sun Pharmaceutical Industries | Meals · 2025-01-29 | Winlevi | $31 |
| Lilly USA | Meals · 2025-01-28 | Taltz | $26 |
| Arcutis Biotherapeutics | Meals · 2025-01-28 | Zoryve | $32 |
| Janssen Biotech | Meals · 2025-01-27 | Tremfya | $25 |
| Abbvie | Meals · 2025-01-27 | Skyrizi | $10 |
| Abbvie | Meals · 2025-01-27 | Skyrizi | $8 |
| Lilly USA | Meals · 2025-01-25 | Ebglyss | $34 |
| Organon | Meals · 2025-01-24 | Vtama | $32 |
| Abbvie | Meals · 2025-01-23 | Rinvoq | $8 |
| Arcutis Biotherapeutics | Meals · 2025-01-23 | Zoryve | $17 |
| Abbvie | Meals · 2025-01-22 | Rinvoq | $34 |
| Abbvie | Meals · 2025-01-22 | Rinvoq | $13 |
| Genzyme | Meals · 2025-01-22 | Dupixent | $37 |
| Janssen Biotech | Meals · 2025-01-21 | Tremfya | $30 |
| Abbvie | Meals · 2025-01-21 | Skyrizi | $17 |
| Genzyme | Meals · 2025-01-21 | Dupixent | $9 |
| Abbvie | Meals · 2025-01-10 | Rinvoq | $27 |
| LEO Pharma | Meals · 2025-01-10 | Adbry | $10 |
| Abbvie | Meals · 2025-01-09 | Skyrizi | $17 |
| Galderma Laboratories L.P. | Meals · 2025-01-09 | None | $30 |
| Lilly USA | Meals · 2025-01-08 | Taltz | $15 |
| Genzyme | Meals · 2025-01-06 | Dupixent | $48 |
| Organon | Meals · 2025-01-04 | Vtama | $14 |
| Abbvie | Meals · 2025-01-03 | Skyrizi | $27 |
| Novartis Pharmaceuticals | Meals · 2025-01-02 | Cosentyx | $35 |
See earlier years (2024, 2023, 2022)
2024: $8,262
| Abbvie | Skyrizi | $2,588 | 75 payments
|
| Genzyme | Dupixent | $1,026 | 23 payments
|
| Lilly USA | Taltz | $916 | 27 payments
|
| Arcutis Biotherapeutics | Zoryve | $558 | 13 payments
|
| LEO Pharma | Adbry | $360 | 25 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $329 | 12 payments
|
| Sun Pharmaceutical Industries | Ilumya | $299 | 11 payments
|
| Regeneron Healthcare Solutions | Dupixent | $294 | 8 payments
|
| Novartis Pharmaceuticals | Cosentyx | $277 | 12 payments
|
| Janssen Biotech | Tremfya | $265 | 8 payments
|
| Incyte | Opzelura | $231 | 13 payments
|
| Ucb | Bimzelx | $227 | 8 payments
|
| Amgen | Otezla | $188 | 4 payments
|
| Dermavant Sciences | Vtama | $183 | 6 payments
|
| Pfizer | Litfulo | $137 | 7 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $108 | 2 payments
|
| Galderma Laboratories L.P. | None | $96 | 4 payments
|
| Ortho Dermatologics a division of Bausch Health US | Cabtreo | $92 | 4 payments
|
| Eli Lilly and | None | $90 | 1 payment
|
2023: $6,464
| AbbVie | Skyrizi | $1,798 | 55 payments
|
| LEO Pharma | Adbry | $841 | 37 payments
|
| Lilly USA | Taltz | $575 | 19 payments
|
| Amgen | Otezla | $478 | 17 payments
|
| Genzyme | Dupixent | $331 | 14 payments
|
| Incyte | Opzelura | $323 | 7 payments
|
| Galderma Laboratories L.P. | None | $318 | 6 payments
|
| Pfizer | Litfulo | $280 | 7 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $279 | 8 payments
|
| Regeneron Healthcare Solutions | Dupixent | $271 | 7 payments
|
| Sun Pharmaceutical Industries | Winlevi | $258 | 9 payments
|
| Dermavant Sciences | Vtama | $217 | 8 payments
|
| Janssen Biotech | Tremfya | $200 | 8 payments
|
| STRATA Skin Sciences | Xtrac | $58 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Cyltezo | $46 | 2 payments
|
| Merz North America | None | $34 | 1 payment
|
| Journey Medical | None | $32 | 1 payment
|
| Biofrontera | Ameluz | $29 | 1 payment
|
| Arcutis Biotherapeutics | None | $28 | 1 payment
|
| Ortho Dermatologics a division of Bausch Health US | Jublia | $27 | 1 payment
|
| Organogenesis | Puraply | $26 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $13 | 1 payment
|
2022: $1,316
| LEO Pharma | Adbry | $271 | 12 payments
|
| Abbvie | Skyrizi | $240 | 8 payments
|
| Genzyme | Dupixent | $235 | 5 payments
|
| STRATA Skin Sciences | Xtrac | $110 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $82 | 3 payments
|
| Regeneron Healthcare Solutions | Dupixent | $68 | 2 payments
|
| Novartis Pharmaceuticals | Cosentyx | $66 | 3 payments
|
| Incyte | Opzelura | $53 | 2 payments
|
| Lilly USA | Taltz | $49 | 2 payments
|
| Ucb | Cimzia | $34 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $33 | 1 payment
|
| Dermavant Sciences | Vtama | $27 | 1 payment
|
| Galderma Laboratories L.P. | None | $25 | 1 payment
|
| Sun Pharmaceutical Industries | Ilumya | $24 | 1 payment
|
Professional record
- NPI
- 1356846588
- Licence
- CA A178808California A178808: Current · expires 2028-05-31
- Trained
- Perelman School of Med at the University of Pennsylvania, 2018 · 8 years ago
- Group
- Csi Medical Group
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 3838 California St Rm 610, San Francisco, CA, 94118
- NPI first listed
- 2018-03-28
- NPI last updated
- 2024-03-08
- NPI record certified
- 2024-03-08
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1800 Sullivan Ave Rm 403, Daly City, CA, 94015 · 2001 Union St Ste 520, San Francisco, CA, 94123 · 2555 Ocean Ave Ste 203, San Francisco, CA, 94132 · 45 Castro St Ste 332, San Francisco, CA, 94114